The application relates generally to medical devices, and more particularly to a system, apparatus, and associated methods for assisting a subject’s heart to pump blood (e.g., a circulatory assist pump).
U.S. Pat. 8,617,239 to Reitan (Dec. 13, 2013), the contents of which are incorporated herein by this reference, relates to a catheter pump to be positioned in the ascending aorta near the aortic valve of a human being, comprising an elongated sleeve with a drive cable extending through the sleeve and connectable at its end to an external drive source and a drive rotor near the distal end of the drive cable mounted on a drive shaft being connected with the drive cable. The drive rotor consists of a propeller enclosed in a cage and the propeller and the cage are foldable from an insertion position close to the drive shaft to an expanded working position, which are characterized by means for anchoring the drive rotor in the ascending aorta near the aortic valve after insertion. Also described is a method to position the pump of a catheter pump in the ascending aorta just above the aortic valve.
U.S. Pat. 8,617,239 to Reitan builds upon an earlier patent of Reitan, i.e., U.S. Pat. 5,749,855 to Reitan (May 12, 1998), the contents of which are also incorporated herein by this reference, which relates to a drive cable, with one end of the drive cable being connectable to a drive source and a collapsible drive propeller at the other end of the drive cable. The collapsible drive propeller is adjustable between a closed configuration in which the collapsible drive propeller is collapsed on the drive cable and an open configuration in which the collapsible drive propeller is expanded so as to be operative as an impeller. A sleeve extends between one side of the collapsible drive propeller and the other side of the collapsible drive propeller with the sleeve being movable between configurations in which the collapsible drive propeller is in the open and closed configuration. A lattice cage is arranged surrounding the propeller and is folded out at the same time as the propeller. As described by U.S. Pat. 8,617,239 to Reitan, while the device of U.S. Pat. 5,749,855 operates very well in many circumstances, there is still room for improvement.
An even earlier blood pumping catheter is described in U.S. Pat. 4,753,221 to Kensey et al. (Jun. 28, 1988), the contents of which are incorporated herein by this reference. Kensey et al. relates to an elongated catheter for pumping blood through at least a portion of a subject’s vascular system. The catheter is of a sufficiently small diameter and flexibility to enable it to be passed through the vascular system so that the distal end portion of the catheter is located within or adjacent the patient’s heart. A rotatable pump is located at the distal end of the catheter and is rotated by drive means in the catheter. The distal end portion of the catheter includes an inlet for blood to flow therein and an outlet for blood to flow therefrom. The catheter is arranged so that blood is pumped by the catheter’s pump through the heart and into the vascular system without requiring any pumping action of the heart.
Other catheter pumps are known from U.S. 2008/0132748 A1, U.S. 2008/0114339A1, and WO03/103745A2, the contents of each of which are incorporated herein by this reference.
Described, among other things herein, is a minimally invasive circulatory support platform that utilizes an aortic stent pump. The platform uses a low profile, catheter-based technique and can be used to provide temporary and/or chronic circulatory support depending on the needs of the subject or patient (e.g., a mammal, such as a human).
In certain embodiments, the described device may include a battery (or electrical storage device) powered circulatory assist pump (or pumps) positioned within an aortic stent which may be wirelessly charged with an abdominal belt.
The described platform and system are relatively easy to place, have higher flow rates than existing systems, and provide improvements in a patient’s renal function. The chronic circulatory assist device (which is removable) is placed within an aortic stent that is preferably wirelessly powered. The impeller is shaped and designed to maximize safety and blood flow and to reduce the risk of hemolysis.
In use, the catheter may be introduced “percutaneously” into the lower aorta via, e.g., the normal “Seldinger technique” in the groin (a small incision into the femoral artery) and fed up to the aorta to the desired position (e.g., the descending aorta). The pump may be inserted in the groin area and introduced into the femoral artery (e.g., to just above the renal arteries in the descending aorta) with the help of a small surgical insertion and insertion sheath. The pump is thereafter fed up into the desired position in the lower aorta.
Alternatively, the pump may be placed via axillary entry in the neck or chest of the subject. See, e.g., K M. Doersch “Temporary Left Ventricular Assist Device Through an Axillary Access is a Promising Approach to Improve Outcomes in Refractory Cardiogenic Shock Patients,” ASAIO J. 2015 May-Jun; 61(3): 253-258; doi: 10.1097/MAT.0000000000000222, the contents of which are incorporated herein by this reference, which describes implantation of a temporary left ventricular assist device (“LVAD”) through an axillary approach as a way to provide adequate circulation to the patient, avoid multiple chest entries and infection risks.
In some embodiments, a battery and motor are utilized to drive the pump. An external belt may be provided that wirelessly charges the battery.
The external belt or vest (electric powered coil inside that extends along the length of the belt such that the coil surrounds the patient’s abdomen when worn) and appropriate circuitry, which belt or vest provides an electromagnetic field. For example, a transmitting coil associated with the belt or vest transmits AC energy, which is received by a receiving coil associated with the wireless pump, which DC energy can be used to power a motor (e.g., pump) and/or a battery. In certain embodiments, the system is controlled, e.g., by a watch (not shown) connected wirelessly to the belt, vest, or controller.
Also described are methods for providing circulatory assist to a subject in need thereof, the method comprising: using the described systems to provide circulatory assist to the subject. Such methods include methods where a “puckless” TET is positioned within a patient’s vasculature such as within the aorta, including the descending aorta.
An aspect of the disclosure is a circulatory assist pump, generally 10, shown in
The depicted circulatory assist pump includes a positioning cable 18 running along the impeller axis, about which the impeller blades 14, 16 (along with the rest of the device) rotate to create a pump action, for example, in the aorta. The arm-like nature of the depicted blades allows them to extend maximally from the remainder of the body when in a perpendicular position and fill a large portion of the descending aorta. At the end of the positioning cable is a rod 20 that interacts with a cam portion 22 of each impeller blade 14, 16. Advancing (or relatively displacing) the rod 20 so that it abuts and actuates the cam portion 22 causes the withdrawn impeller (
An aortic stent cage surrounds the impeller (see, e.g.,
The pump may be placed, for example, above the renal arteries in the aorta to aid in kidney function. More flow into the kidneys means more rapid removal of excess fluids, which leads to better revival of kidney function. In certain embodiments, the system preferably uses the full diameter of the aorta to increase pump stability and reduce pump migration.
In certain embodiments, the system includes implanted sensors that assist with a real time, automatic adjustment and management of the circulatory assist support system based upon data provided by the implanted (preferably wireless) sensors. The sensors monitor fluid flow and provide feedback and data to the system, which feedback and data is used to, e.g., adjust the speed and/or angle of the impeller to increase or decrease fluid flow and pressure.
The wireless power embodiment is designed to reduce infection risk compared to external drive line systems. Also, the wireless power option helps improve the patient’s quality of life.
Optionally, the system may be utilized with an upper aorta pulsating aortic cuff stent graft, which improves the total flow of the system, improves hemodynamics, (via the pulsatile flow) improves the release of beneficial proteins for organ health, and reduces RPMs needed by the impeller to reach desired flow rates.
In certain embodiments, elements of a system and/or device as described herein (e.g., impeller blade(s), drive shaft, and/or stent cage) are coated with a hydrophobic or lubricous material to reduce the potential for endothelialization after placement of the device. Such a material can be, for example, expanded polytetrafluorethylene (ePTFE available from Gore Technologies) or similar graft liner.
In some embodiments, such as shown in
The stent cage 108 may be configured to securely position the wireless circulatory assist pump 100 in a patient’s aorta, while maintaining the pulsatility of the aorta. Additionally, the stent cage 108 may be compressed and stowed for placement and removal of the wireless circulatory assist device 100.
The motor 114 may be a miniature brushless direct current (“DC” or “BLDC”) motor. For example, the motor 114 may be a miniature brushless DC motor such as available under the tradename “EC6” from Maxon Precision Motors, Inc. of Foster City, California US. A BLDC motor, electronically commutated motor (ECM or EC motor) or synchronous DC motor, is a synchronous motor using a direct current (DC) electric power supply. An ASIC may be used to control BLDC motor and telemetry in the mechanical circulatory assist device system.
The battery 110 may be a rechargeable battery, such as a lithium-ion battery. For example, the battery 110 may be a 3 milliamp hour (mAh) lithium-ion battery available under the tradename “CONTIGO” from EaglePicher Technologies of Joplin, Missouri USA. For another example, the battery 110 may be a 3 mAh lithium-ion battery available under the tradename “MICRO3-QL0003B” from Quallion LLC of Sylmar, California USA. It will be understood, however, that the battery 110 may be of any suitable chemistry and/or type, including non-chemical electric power storage devices, such as a capacitor (e.g., a supercapacitor, ultracapacitor, or double-layer capacitor).
The wireless charging circuit may produce an electric current in response to an applied electric field, magnetic field, and/or electromagnetic field, which may be utilized to charge the battery 110. Additionally, the wireless charging circuit may include an induction coil assembly, which will be further described with reference to
The communication circuit may be configured to send and receive data via wireless communication. For example, the communication circuit may be configured to send and receive data utilizing radio communication (e.g., WiFi, Bluetooth, etc.) In some embodiments, the communication circuit may be utilized to send data collected from one or more sensors of the wireless circulatory assist pump 100. For example, the communication circuit may be utilized to send data relating to the rotational speed of the pump, upstream and downstream fluid pressures, battery charge status, motor status, impeller status, and/or other measured conditions.
The control circuit may be utilized to control certain operations of the wireless circulatory assist pump 100. In some embodiments, the control circuit may be utilized to control the rotational speed of the motor 114, the shape of the impeller 106, the deployment of the impeller blades 116, the stowing of the impeller blades 116, the angle of the impeller blades 116, and/or other operations of the circulatory assist pump 100.
In some embodiments, the circulatory assist pump 100 may comprise one or more application-specific integrated circuit (“ASIC”) chips. For example, one or more of the charging circuit, the communication circuit, and the control circuit may be provided as one or more ASIC chips.
Electromagnetic waves may be delivered non-invasively from an abdominal belt 150, as shown in
Once fitted onto the patient, the abdominal belt 150 (or vest, not shown) is typically configured to deliver electromagnetic waves at a relatively low frequency (e.g., below gigahertz, and preferably below megahertz) using a flux field. The particular frequency transmitted will be chosen based upon, e.g., the number of lining(s), windings of coil(s), and the type and mass of materials used in the particular wireless pump 100. For example, the abdominal belt 150 may be configured to deliver electromagnetic waves at a frequency between about 50 kHz and about 300 kHz. For another example, the abdominal belt 150 may be configured to deliver electromagnetic waves at a frequency between about 100 kHz and about 150 kHz. In yet another example, the abdominal belt 150 may be configured to deliver electromagnetic waves at a frequency of about 125.3 kHz. Preferably, the frequency will be about (within 25% of) 123.5 kHz, which greatly reduce SAR (i.e., below AM and close to audible) and result in less heating, with more efficient and easier energy transfer to the motor and/or a battery associated with the wireless pump.
As shown in
Delivering the electromagnetic energy from the coils 152 surrounding the entire circumference of a patient’s abdomen to the wireless charging circuit at a relatively low frequency may have many advantages over traditional transcutaneous energy transmission (“TET”) systems that utilize a relatively small puck (e.g., having a diameter between about 2-3 inches) that delivers energy at a relatively high frequency. First, the distribution of relatively low frequency electromagnetic waves over a relatively large area, may reduce the heating of body tissue when compared to a relatively small puck that delivers energy at a relatively high frequency. Second, the distribution of relatively low frequency electromagnetic waves over a relatively large area may improve the reliability and range of the energy delivery to the wireless charging circuit of the implanted device. The relatively low frequency electromagnetic waves may travel more efficiently through relatively dense materials, such as body tissue. Accordingly, while small puck devices that deliver relatively high frequency electromagnetic energy may require precise alignment to reliably deliver energy, the wireless charging circuit and the abdominal belt 150 delivering relatively low frequency electromagnetic waves may be rotated up to 45 degrees relative to one another and reliable energy transfer may still occur.
Referring again to
In some embodiments, the impeller blades 116 may be configured to rotate or twist to selectively vary the pitch of the impeller blades 116. In some embodiments, the impeller blades 116 may be configured to bend to selectively alter the curvature of the impeller blades 116.
Certain impeller shapes and curvatures can optimize blood flow and minimize hemolysis in both chronic implantable and temporary circulatory assist devices. Most of these ideal optimized shapes, however, are not practical for delivery via a percutaneous non-surgical delivery catheter. Additionally, not one impeller shape appears to be ideal for all circumstances to best meet patient needs at all times. Accordingly, impellers 106 according to embodiments of the disclosure may change shape on demand to meet patient needs as they arise that can be delivered and removed without surgery. Traditionally, these ideal impeller shapes are fixed in shape and cannot be changed without mechanically making a change in manufacturing.
As previously discussed, the distal tip end 102 of the circulatory assist pump 100 may house the battery 110, the wireless charging circuit, the communications circuit, the control circuit, and the motor 114. The end of the distal tip end 102 may have a smooth, generally dome shaped, leading end. This may prevent harm to the patient should the distal tip end 102 come into contact with the arterial wall, such as during an insertion or removal procedure. The distal tip end 102 may comprise a canister covering and sealing the components therein. In some embodiments, a titanium canister may cover and seal the distal tip end 102.
In yet additional embodiments, the canister may comprise at least a portion that is made of a material that is transparent to certain frequencies of electromagnetic radiation, magnetic fields, and/or electrical fields, such as a ceramic (“sealed ceramic”) or a polymer, to facilitate electromagnetic, electric, and/or magnetic communication between devices located outside of the patient’s body (e.g., the abdominal belt 150) and components within the distal tip end 102 (e.g., the first coil 162 of the charging circuit). For example, the use of a ceramic fused to the titanium canister provides for radio frequency (RF) transparency or translucency.
The proximal docking end 104 of the circulatory assist pump 100 may comprise features configured to interact with one or more catheter, such as a deployment catheter 130 (
In certain embodiments described herein, a self-aligning magnetic design is utilized for the device docking and retrieval catheter(s).
To install the circulatory assist pump 100 a deployment catheter 130 may be provided having a tip configured to hold and then release the circulatory assist pump 100, as shown in
When the inner member 134 and the fingers 136 are extended out of the outer sheath 132, the tips of the fingers 136 may be biased radially outward and apart from one another. Each finger may comprise a protrusion 138 at the tip, which may be spaced sufficiently apart that the proximal docking end 104 may freely pass between the protrusions 138. Accordingly, the proximal docking end 104 may be positioned adjacent to the inner member 134, and the protrusions 138 may surround the annular groove 118 of the proximal docking end 104.
The outer sheath 132 may then be extended over the inner member 134 and the plurality of fingers 136. As the outer sheath 132 extends over the fingers 136, the outer sheath 132 may force the tips of the fingers 136 radially inward and the protrusions 138 of the fingers 136 may be positioned within the annular groove 118 of the proximal docking end 104 of the circulatory assist pump 100, and prevent movement of the proximal docking end 104 relative to the inner member 134 and the fingers 136. The blades 116 of the impeller 106 may be placed into a stowed position and the stent cage 108 may be retracted. In some embodiments the blades of the impeller 116 and the stent cage 108 may be withdrawn into the outer sheath 132. For example, embodiments that utilize a shape change impeller 106A, may have impeller blades 116A with sufficient flexibility that the impeller blades 116A may naturally fold and conform as the impeller blades 116A are withdrawn into the outer sheath 132.
The tip of the deployment catheter 130 and the attached circulatory assist pump 100 may then be positioned within a patient to a desired location for deployment of the circulatory assist pump 100. The resilient material of the stent cage 108 may expand to contact the patient’s vessel wall and hold the circulatory assist pump 100 in place. Then, the outer sheath 132 may be withdrawn from the fingers 136 and the inner member 134. As the outer sheath 132 is withdrawn, the tips of the fingers 136 may be biased radially apart and the protrusions 138 of the fingers 136 may be withdrawn from the annular groove 118, disconnecting the deployment catheter 130 from the proximal docking end 104. The deployment catheter 130 may then be removed from the patient with the circulatory assist pump 100 left in place.
To remove the circulatory assist pump 100, a retrieval catheter 140 having a tip such as shown in
When the inner member 144 and the fingers 146 are extended out of the outer sheath 142, the tips of the fingers 146 may be biased radially outward and apart from one another. Each finger 146 may comprise a protrusion 150 at the tip, which may be spaced sufficiently apart that the proximal docking end 104 may freely pass between the protrusions 150. Accordingly, the proximal docking end 104 may be positioned adjacent to the inner member 134, and the magnetic ball 148 may be attracted to the ferromagnetic material of the proximal docking end 104 and become seated within the generally hemispherical indentation 120 in the proximal docking end 104 and magnetically coupled thereto. Upon the seating and magnetic coupling of the magnetic ball 148 to the proximal docking end 104, the protrusions 150 may surround the annular groove 118 of the proximal docking end 104.
The outer sheath 142 may then be extended over the inner member 144 and the plurality of fingers 146. As the outer sheath 142 extends over the fingers 146, the outer sheath 142 may force the tips of the fingers 146 radially inward and the protrusions 150 of the fingers 146 may be positioned within the annular groove 118 of the proximal docking end 104 of the circulatory assist pump 100, and prevent movement of the proximal docking end 104 relative to the inner member 144 and the fingers 146. The blades 116 of the impeller 106 may be placed into a stowed position and the stent cage 108 may be retracted from the artery wall. In some embodiments the blades of the impeller 116 and the stent cage 108 may be withdrawn into the outer sheath 142. For example, embodiments that utilize a shape change impeller 106A, may have impeller blades 116A with sufficient flexibility that the impeller blades 116A may naturally fold and conform as the impeller blades 116A are withdrawn into the outer sheath 142. The retrieval catheter 140 and circulatory assist pump 100 may then be removed from the patient.
Also described herein is chronic, wireless mechanical circulatory assist device (MCAD) and system, which may be percutaneously placed into the descending thoracic aorta above the kidneys of a subject with, for instance, the aid of placement and retrieval catheters (e.g., 14 Fr), and utilized in the treatment of, for example, heart failure and associated renal dysfunction.
In a preferred embodiment, the wireless MCAD system includes an aortic wireless pump, an appropriately sized wearable vest or belt for providing energy to drive the wireless pump, while the wireless pump is powered and controlled by a, e.g., radio frequency (RF) control unit with power pack.
The aortic wireless pump in such a preferred system typically includes a radial force nitinol stent cage, which expands up to, e.g., 22 mm in deployment in an adult male. Such a size for the wireless pump allows for secure placement in the aorta, while allowing the aorta to maintain its puslatility. Aortic pulsatility is ideal for extended use applications.
A presently preferred wireless pump is depicted, e.g., in
The wireless pump 100 depicted in
The motor and/or battery can be placed within a sealed canister (e.g., titanium or stainless steel).
Placement of the circuitry, motor, and battery near the distal tip causes the wireless pump to have its primary weight at the top of the device, which helps to mitigate positional movement by impact (e.g., jumping). This configuration also increases the radial force of the stent cage of the wireless pump.
The radial force stent cage 108 is configured to securely position the wireless pump 100 in a particular patient’s aorta, while maintaining the aorta’s pulsatility. Additionally, the stent cage 108 may be compressed and stowed for placement and removal of the wireless circulatory assist device 100.
The motor 114 is preferably a miniature brushless direct current (“DC” or “BLDC”) motor. A BLDC motor, electronically commutated motor (ECM or EC motor) or synchronous DC motor, is a synchronous motor using a direct current (DC) electric power supply. Such a brushless motor preferably has a relatively small diameter (e.g., < 14 Fr), but the diameter could be larger dependent on the application. An ASIC may be used to control BLDC motor and telemetry in the mechanical circulatory assist device system. A drive shaft 113 connects the motor to the impeller 106.
Percutaneous placement of the wireless pump using the placement/retrieval catheter (by, e.g., femoral arterial access) can be surgically accomplished in about two minutes.
Once properly placed in the subject’s aorta, there is typically no need for repositioning of the wireless aortic pump, which alleviates the need for hooks or paddles that might damage the wall of the aorta.
Further, the aortic wireless pump utilizes a relatively low speed and is shown to have ultra-low hemolysis. The speed of the aortic wireless pump (in RPM) in certain embodiments is set at a chosen RPM. In certain embodiments, however, closed loop feedback and/or differential pressure management is used to adjust the RPM of the wireless pump appropriately.
Wireless transcutaneous energy transfer (TET) is preferably used to operate and provide power to the wireless pump 100 (i.e., without utilizing a separate “puck” or separate subcutaneous receiving (Rx) coil device). See, e.g., G. E. Loeb, R. A. Peck, W. H. Moore, and K. Hood. Bion system for distributed nerual prosthetic interfaces. Medical Engineering and Physics, 23(1):9-18, January 2001; and U.S. Pat. 7,005,935 to Moore (Feb. 28, 2006) for “Switched reactance modulated E-class oscillator”. The resulting lack of wires in the aorta and/or femoral arteries reduces the risk of infection.
Preferably, ultralow power magnetic induction power transmission is used to power and control such a wireless pump. This results in truly wireless operation, with little to no heat generation. The system utilizes a low frequency design with extremely conservative operating frequencies and extraordinarily low specific absorption rate (SAR) value. SAR is a measure of the rate at which energy is absorbed per unit mass by a human body when exposed to a radio frequency (RF) electromagnetic field. It is defined as the power absorbed per mass of tissue and has units of watts per kilogram (W/kg).
The wireless pump is further preferably configured so that the magnetic flux (or flux area) of the wireless pump accommodates angles of anatomical variability so that the device maintains constant operation.
In certain embodiments, the wireless pump further includes a sensor 111 or sensors in one or more ends of the wireless pump (e.g., at the end 102, proximal 112 of
After placement, the wireless pump can be removed by generally reversing the deployment procedure (see, e.g.,
The RF control unit (with power pack) of the MCAD system preferably operates for at least 36 hours on a primary rechargeable battery. The RF control unit is also preferably provided with an indicator and a secondary battery that adds an additional 36 hours of operation. U.S. Pat. 7,177,690 to Woods et al. (Feb. 13, 2007) for “Implantable system having rechargeable battery indicator”. The secondary battery is readily swappable with the primary rechargeable battery to prevent a disruption of operation.
In certain embodiments, the RF control unit is constructed to be splash proof/water resistant to 3 ATM (30 m). In certain embodiments, the RF control unit may also be relatively lightweight and readily mounted onto a belt or integrated pouch on the vest of the MCAD system.
In certain preferred embodiments, the RF control unit is Bluetooth-enabled so as to provide functional support and status, including providing information to a health care professional.
The vest of the MCAD system is preferably lightweight and flexible, having a breathable / washable fabric outer shell. The vest is typically made of cloth, having straps and, e.g., Velcro ® adjustments. The vest preferably has an accessible front connector for easy connection or detachment. It is further also preferably constructed to be splash proof/water resistant.
The MCAD system, once properly placed and implemented, augments native flow through the aorta with as much as an additional four (4) liters of blood per minute.
While certain illustrative embodiments have been described in connection with the figures, those of ordinary skill in the art will recognize and appreciate that the scope of this disclosure is not limited to those embodiments explicitly shown and described in this disclosure. Rather, many additions, deletions, and modifications to the embodiments described in this disclosure may be made to produce embodiments within the scope of this disclosure, such as those specifically claimed, including legal equivalents. In addition, features from one disclosed embodiment may be combined with features of another disclosed embodiment while still being within the scope of this disclosure.
(the contents of each of which are incorporated herein by this reference.)
Brancato, Luigi et al. “An Implantable Intravascular Pressure Sensor for a Ventricular Assist Device.” Micromachines vol. 7, 8 135. 8 Aug. 2016, doi:10.3390/mi7080135.
G. E. Loeb, R. A. Peck, W. H. Moore, and K. Hood. Bion system for distributed nerual prosthetic interfaces. Medical Engineering and Physics, 23(1):9-18, January 2001.
U.S. Pat. 4,753,221 to Kensey et al. (Jun. 28, 1988).
U.S. Pat. 5,749,855 to Reitan (May 12, 1998).
U.S. Pat. 7,005,935 to Moore (Feb. 28, 2006) for “Switched reactance modulated E-class oscillator”.
U.S. Pat. 7,177,690 to Woods et al. (Feb. 13, 2007) for “Implantable system having rechargeable battery indicator”.
U.S. Pat. 7,437,193 to Parramon et al. (Oct. 14, 2008) for “Microstimulator employing improved recharging reporting and telemetry techniques”.
U.S. Pat. 7,599,743 to Hassler, Jr. et al. (Oct. 9, 2009) for “Low Frequency Transcutaneous Energy Transfer to Implanted Medical Device”.
U.S. Pat. 8,617,239 to Reitan (Dec. 31, 2013) for “Catheter Pump”.
U.S. Pat. 8,727,959 to Reitan et al. (May 20, 2014) for “Catheter Pump for Circulatory Support”.
U.S. Pat. 10,179,197 to Kaiser et al. (Jan. 15, 2019) for “Catheter Pump with a Pump Head for Insertion into the Aorta”.
U.S. Design Pat. 811,588 to Kaiser et al. (Feb. 27, 2018) for “Cage for Catheter Pump”.
U.S. Pat. Application 20200023158 A1 to Epple (Jan. 23, 2020) for “Flushing System”.
U.S. Pat. Application 20200000988 A1 to Epple (Jan. 2, 2020) for “Catheter pump comprising drive unit and catheter”.
U.S. Pat. Application 20200023109 A1 to Epple (Jan. 23, 2020) for “Catheter pump having a pump head for introducing into the arterial vasculature”.
WO 1994005347 A1 to Reitan (Mar. 17, 2994) for “Catheter Pump”.
U.S. Pat. Application 20200023113 A1 to Epple et al. (Jan. 23, 2020) for “Catheter pump with drive unit and catheter”.
U.S. Pat. Application 20020087204 A1 to Kung et al. (Jan. 4, 2001) for “Flexible transcutaneous energy transfer (TET) primary coil”.
U.S. Pat. Application 20210077687 A1 to Leonhardt (Mar. 18, 2021) for “Circulatory Assist Pump”.
International Patent Publication WO 2019/183247 A1 (Sep. 26, 2019) for “Circulatory Assist Pump”.